Journal of Pharmacobio-Dynamics · 1983 · 12 citations · 24 references
MedicineBiochemistryPharmacologyBiochemical PharmacologyDrug MetabolismEnzymologyCytochrome P450 EnzymesEnzyme InductionEnzyme InhibitionHeme MetabolismHepatic Drug MetabolismHepatic MetabolismAla Synthase RegulationCytochrome P450 Enzyme ActivityCytochrome P450 Enzyme InhibitionCytochrome P450 InhibitionCytochrome P450 IsoenzymesIn Vivo StudiesMetabolic Enzyme InhibitionMetabolizing Enzyme Induction
Thioacetamide and one of its metabolite, thioacetamide-S-oxide, were shown to increase heme oxygenase and to inhibit delta-aminolevulinic acid (ALA) synthetase when administered in vivo to male rats. Concomitant with the increase of heme oxygenase and the decrease of ALA synthetase, concentration of cytochrome P-450 and drug metabolizing enzyme activities were decreased by in vivo administration of thioacetamide and thioacetamide-S-oxide to rats. The results of these studies indicate that thioacetamide and thioacetamide-S-oxide are not only inhibitor of ALA synthetase, but also inducer of heme oxygenase in rats. Further, thioacetamide-S-oxide is generally more effective than thioacetamide with respect to the effects on cytochrome P-450, ALA synthetase and heme oxygenase.
24
The Carbon Monoxide-binding Pigment of Liver Microsomes
Tsuneo Omura, Ryo Sato · Journal of Biological Chemistry · 1964 · 11.8K citations · Full text